Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial
| Autor: | Victor M. Herrera, Zulma M. Cucunubá, Yeny Zulay Castellanos Domínguez, Eliana Váquiro Herrera, Juan Carlos Villar, Skarlet Marcell Vásquez, Nilda Graciela Prado, Juan Guillermo Pérez Carreño, Yolanda Hernández |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Enfermedad de Chagas Medicine (miscellaneous) Placebo Asymptomatic law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Internal medicine medicine Pharmacology (medical) 030212 general & internal medicine Nifurtimox Trypanosoma cruzi Equivalence (measure theory) lcsh:R5-920 biology business.industry medicine.disease biology.organism_classification Benznidazole medicine.symptom Ensayos Clínicos Controlados Aleatorios lcsh:Medicine (General) business Trypanosomiasis 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Sistema de Gestión del Conocimiento ANLIS MALBRÁN Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" instacron:ANLIS Trials, Vol 20, Iss 1, Pp 1-2 (2019) |
| Popis: | Fil: Hernández Yolanda. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Parasitología Dr. Mario Fatala Chaben. Departamento de Clínica, Patología y Tratamiento; Argentina. Following publication of the original article [1], the authors notified us of a few requested editions that were not implemented adequately during proofing. The publisher apologizes for the inconvenience caused to our authors and readers. Correction to: Trials https://doi.org/10.1186/s13063-019-3423-3 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|